Rituximab as monotherapy for the treatment of chronic active antibody ‐mediated rejection after kidney transplantation

Transplant International,Volume 31, Issue 4, Page 451-455, April 2018.
Source: Transplant International - Category: Transplant Surgery Source Type: research